HK1064030A1 - Use of lanthanum carbonate for the prevention of kidney stone disease - Google Patents

Use of lanthanum carbonate for the prevention of kidney stone disease

Info

Publication number
HK1064030A1
HK1064030A1 HK04106196.5A HK04106196A HK1064030A1 HK 1064030 A1 HK1064030 A1 HK 1064030A1 HK 04106196 A HK04106196 A HK 04106196A HK 1064030 A1 HK1064030 A1 HK 1064030A1
Authority
HK
Hong Kong
Prior art keywords
lanthanum carbonate
oxalate
adjusted
buffer
prevention
Prior art date
Application number
HK04106196.5A
Other languages
English (en)
Inventor
Michael J Abrams
Gary J Bridger
Simon P Fricker
Stefan R Idzan
Original Assignee
Shire Int Licensing Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Int Licensing Bv filed Critical Shire Int Licensing Bv
Publication of HK1064030A1 publication Critical patent/HK1064030A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
HK04106196.5A 2001-04-23 2004-08-18 Use of lanthanum carbonate for the prevention of kidney stone disease HK1064030A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28590101P 2001-04-23 2001-04-23
PCT/US2002/013000 WO2002085348A1 (en) 2001-04-23 2002-04-22 Use of rare earth compounds for the prevention of kidney stone disease

Publications (1)

Publication Number Publication Date
HK1064030A1 true HK1064030A1 (en) 2005-01-21

Family

ID=23096166

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04106196.5A HK1064030A1 (en) 2001-04-23 2004-08-18 Use of lanthanum carbonate for the prevention of kidney stone disease

Country Status (26)

Country Link
US (2) US7192609B2 (de)
EP (1) EP1389102B1 (de)
JP (2) JP4515030B2 (de)
KR (1) KR100956013B1 (de)
CN (1) CN100438866C (de)
AT (1) ATE499943T1 (de)
AU (2) AU2002307543B2 (de)
BR (1) BR0209072A (de)
CA (1) CA2442414C (de)
CY (1) CY1112049T1 (de)
CZ (2) CZ298280B6 (de)
DE (2) DE20221760U1 (de)
DK (2) DK1389102T3 (de)
ES (1) ES2362271T3 (de)
FI (1) FIU20060390U0 (de)
HK (1) HK1064030A1 (de)
HU (1) HUP0303938A3 (de)
MX (1) MXPA03009668A (de)
NO (1) NO20034704L (de)
NZ (1) NZ528818A (de)
PL (1) PL370642A1 (de)
PT (1) PT1389102E (de)
RU (1) RU2296584C2 (de)
SI (1) SI1389102T1 (de)
WO (1) WO2002085348A1 (de)
ZA (1) ZA200308112B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1660104T3 (da) * 2003-08-26 2010-06-21 Shire Holdings Ag Farmaceutisk formulering indeholdende lanthanforbindelser
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
KR101072196B1 (ko) * 2004-07-27 2011-10-10 샤이어 파마세우티컬, 인크. 란탄 하이드록시 카보네이트를 이용한 고인산증 치료 방법
US20070104799A1 (en) * 2005-11-09 2007-05-10 Shire International Licensing B.V. Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds
WO2009118760A2 (en) * 2008-03-26 2009-10-01 Matrix Laboratories Limited Lanthanum composition
US8961917B2 (en) 2010-05-12 2015-02-24 Spectrum Pharmaceuticals, Inc. Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
RU2657755C1 (ru) * 2017-07-10 2018-06-15 Александр Александрович Кролевец Способ получения нанокапсул солей лантаноидов в каррагинане
WO2021163574A1 (en) * 2020-02-13 2021-08-19 Lawrence Livermore National Security, Llc Methods of sequestering target elements
WO2024003337A1 (en) * 2022-07-01 2024-01-04 Amgmt Orally administrable pharmaceutical dosage form comprising lanthanum and its use in a method of treatment of hyperoxaluria

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1668562C3 (de) * 1967-12-08 1975-01-30 Pharmazeutische Fabrik Evers & Co, 2080 Pinneberg Cergluconat, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Präparate
DE3046580A1 (de) * 1980-12-11 1982-07-01 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
DE3213139A1 (de) * 1980-12-11 1983-10-20 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
JPS614529A (ja) * 1984-06-15 1986-01-10 Asahi Chem Ind Co Ltd リン酸イオンの吸着剤
JPS614528A (ja) 1984-06-15 1986-01-10 Arubatsuku Service Kk 水溶性ガスの高純度溶液の製造装置
JPH06705B2 (ja) 1985-12-19 1994-01-05 旭化成工業株式会社 リン酸イオンの固定化剤
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate
US5342604A (en) * 1988-10-31 1994-08-30 The Dow Chemical Company Complexes possessing ortho ligating functionality
US5696239A (en) * 1988-10-31 1997-12-09 The Dow Chemical Company Conjugates possessing ortho ligating functionality and complexes thereof
EP0620728B1 (de) * 1992-01-13 1997-01-08 Pfizer Inc. Verfahren zur herstellung von tabletten mit hoher festigkeit
RU2061040C1 (ru) 1994-05-23 1996-05-27 Акционерное общество "Русский йогурт" Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для получения препаратов и продуктов питания для профилактики и лечения гипероксалурии
US5562921A (en) * 1994-07-15 1996-10-08 Sherman; Bernard C. Stable solid pharmaceutical compositions containing enalapril maleate
GB9506126D0 (en) 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
US5951958A (en) * 1996-07-10 1999-09-14 Shin-Etsu Chemical Co., Ltd. Method for the preparation of rare earth phosphate of low overstoichiometric phosphorous content
US5902825A (en) * 1997-01-07 1999-05-11 Mitreoak, Ltd. Composition and method for the palliation of pain associated with diseases of the bone and bone joints
DE69841200D1 (de) 1997-05-23 2009-11-12 Oxthera Inc Oxalate-abbauende mikroorganismen oder oxalate-abbauende enzyme zur verhütung der oxalate-verwandten krankheiten
US6355242B1 (en) 1997-05-23 2002-03-12 Ixion Biotechnology, Inc. Materials and methods for treating or preventing oxalate-related disease
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US20010014352A1 (en) * 1998-05-27 2001-08-16 Udit Batra Compressed tablet formulation
US6160016A (en) * 1999-12-22 2000-12-12 Wisconsin Alumni Research Foundation Phosphorus binder
WO2004030669A1 (en) * 2002-09-30 2004-04-15 Schering Corporation Use of tricyclic amides for the treatment of disorders of calcium homeostasis
DK1660104T3 (da) * 2003-08-26 2010-06-21 Shire Holdings Ag Farmaceutisk formulering indeholdende lanthanforbindelser

Also Published As

Publication number Publication date
KR100956013B1 (ko) 2010-05-06
CA2442414A1 (en) 2002-10-31
US20020155168A1 (en) 2002-10-24
SI1389102T1 (sl) 2011-07-29
BR0209072A (pt) 2006-02-07
NO20034704L (no) 2003-11-25
ES2362271T3 (es) 2011-06-30
CZ17802U1 (cs) 2007-09-03
EP1389102A1 (de) 2004-02-18
EP1389102A4 (de) 2004-07-14
AU2006203055A1 (en) 2006-08-10
DK200600251U1 (da) 2007-01-12
RU2296584C2 (ru) 2007-04-10
CA2442414C (en) 2011-02-01
DK1389102T3 (da) 2011-06-06
US7192609B2 (en) 2007-03-20
JP4515030B2 (ja) 2010-07-28
CZ20032880A3 (cs) 2004-01-14
RU2003133991A (ru) 2005-04-20
JP2009173684A (ja) 2009-08-06
HUP0303938A2 (hu) 2004-04-28
JP2005507369A (ja) 2005-03-17
FIU20060390U0 (fi) 2006-09-22
CZ298280B6 (cs) 2007-08-15
WO2002085348A1 (en) 2002-10-31
AU2006203055B2 (en) 2008-12-18
CY1112049T1 (el) 2015-11-04
KR20040018362A (ko) 2004-03-03
US20070116782A1 (en) 2007-05-24
ZA200308112B (en) 2005-01-17
ATE499943T1 (de) 2011-03-15
CN1503668A (zh) 2004-06-09
PT1389102E (pt) 2011-06-07
CN100438866C (zh) 2008-12-03
PL370642A1 (en) 2005-05-30
DE20221760U1 (de) 2007-08-16
DK200600251U4 (da) 2007-12-28
HUP0303938A3 (en) 2012-09-28
NZ528818A (en) 2008-09-26
MXPA03009668A (es) 2004-02-12
AU2002307543B2 (en) 2006-04-27
NO20034704D0 (no) 2003-10-21
DE60239329D1 (de) 2011-04-14
EP1389102B1 (de) 2011-03-02

Similar Documents

Publication Publication Date Title
FIU20060390U0 (fi) Harvinaisten maametalliyhdisteiden käyttö munuaiskivisairauden ehkäisemiseksi
PL370652A1 (en) Liquid composition of factor vii polypeptides
ATE367429T1 (de) Stabilisierte saure chlorbleichmittelzusammensetzung und verfahren zur anwendung
RU94017851A (ru) Ингибиторы протеолитических ферментов на основе производных сахарина, фармацевтическая композиция для лечения дегеративных заболеваний
DE3682025D1 (de) Keimtoetendes und reinigendes mittel fuer trinkwasser.
ATE547114T1 (de) Flüssige zusammensetzungen von factor vii polypeptiden
EP1329461A4 (de) Verfahren zur verhinderung von polymeren des humanen serumalbumins
DE69430805D1 (de) Spüllösung für organe und gewebe
AU7347294A (en) Zeolitic desulfurazation agents and their application to co2-containing gas treatment
DE69908554D1 (de) Verfahren zur reinigung eines sauren gases
Rodionova et al. Ca2+-activator of the luminescence system of the earthworms Henlea sp.,(Annelida: Clitellata: Oligochaeta: Enchytraeidae)
ATE254950T1 (de) Verfahren zur reinigung wässriger pufferlösungen
RU95117286A (ru) Ирригационный раствор для офтальмологических операций
DK0403244T3 (da) Fremgangsmåde til vandbehandling
ATE439136T1 (de) Verfahren zur behandlung von halitose
ATE384705T1 (de) Verfahren zur lagerung von tetrazoliumverbindungen, dafür bestimmter stabilisator und nach dem verfahren aufbewahrte tetrazoliumverbindungsreagenz lösung
RU2003120703A (ru) Способ регенерации костной ткани в эксперименте
RU2003117105A (ru) Состав для обработки материалов
RU99104271A (ru) Состав для химического расширения каналов
BR9813975A (pt) Processo de fabricação de carbonato de cálcio
RU96114220A (ru) Твердый состав для обеззараживания и очистки воды
GR1003896B (el) ΝΕΑ ΜΕΘΟΔΟΣ ΑΠΟΜΟΝΩΣΗΣ ΡΙΒΟΝΟΥΚΛΕΪΚΩΝ ΟΞΕΩΝ (total RNA) ΑΠΟ ΙΣΤΟΥΣ ΠΑΡΑΦΙΝΗΣ
RU99100562A (ru) Способ крепления стенок скважин
IT1253704B (it) Soluzioni terapeutiche stabili per uso iniettabile a base di fruttosio-1,6-difosfato sale di sodio o di calcio o di magnesio
UA13814A (uk) СПОСІБ ПРИСКОРЕHОГО ВИЗHАЧЕНHЯ ЕФЕКТИВHОСТІ СОРБЦІЇ 134Cs В ОРГАHІЗМІ ТВАРИHИ

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150422